Market overview
The global absorbable PGA surgical sutures market is worth USD 228 mn in 2026 and is forecast to reach USD 321 mn by 2036, growing at a 3.5% CAGR. United States is the largest country market and Braided and coated is the largest by construction segment.
| Scope | Synthetic absorbable sutures made of braided polyglycolic acid, sold as coated and uncoated sutures for general, obstetric, orthopaedic and plastic surgery. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 220 mn |
| Value 2026 | USD 228 mn |
| Value 2036 | USD 321 mn |
| CAGR 2026-2036 | 3.5% |
| Volume 2026 | 56.4 million units |
| Volume 2036 | 72.0 million units |
| Average price 2026 | USD 4.04 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Absorbable PGA Surgical Sutures market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 228 mn |
| 2027 | USD 236 mn |
| 2028 | USD 244 mn |
| 2029 | USD 252 mn |
| 2030 | USD 261 mn |
| 2031 | USD 270 mn |
| 2032 | USD 280 mn |
| 2033 | USD 290 mn |
| 2034 | USD 300 mn |
| 2035 | USD 310 mn |
| 2036 | USD 321 mn |
Absorbable PGA Surgical Sutures market segmentation
By construction
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Braided and coated | 72.0% | 74.1% | USD 164 mn | 3.8% |
| Braided uncoated | 18.0% | 16.3% | USD 41 mn | 2.5% |
| Dyed and other | 10.0% | 9.5% | USD 23 mn | 3.0% |
By surgery
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| General surgery | 36.0% | 36.0% | USD 82 mn | 3.5% |
| Obstetrics and gynaecology | 22.0% | 22.0% | USD 50 mn | 3.5% |
| Orthopaedic | 12.0% | 12.0% | USD 27 mn | 3.5% |
| Plastic and ophthalmic | 14.0% | 14.7% | USD 32 mn | 4.0% |
| Other | 16.0% | 15.3% | USD 36 mn | 3.0% |
By needle type
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Round-bodied taper | 46.0% | 44.0% | USD 105 mn | 3.0% |
| Cutting | 34.0% | 34.0% | USD 77 mn | 3.5% |
| Blunt and specialty | 14.0% | 16.0% | USD 32 mn | 4.9% |
| Needle-free ties | 6.0% | 6.0% | USD 14 mn | 3.5% |
By suture size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fine sizes | 28.0% | 29.0% | USD 64 mn | 3.9% |
| Medium sizes | 46.0% | 45.0% | USD 105 mn | 3.3% |
| Heavy sizes | 26.0% | 26.0% | USD 59 mn | 3.5% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 72.0% | 69.0% | USD 164 mn | 3.1% |
| Ambulatory surgery centres | 14.0% | 16.0% | USD 32 mn | 4.9% |
| Clinics | 14.0% | 15.0% | USD 32 mn | 4.2% |
Top 25 countries for absorbable PGA surgical sutures by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 76.0% of 2026 revenue and the 25 countries below together hold 93.7%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 59 mn | 26.0% | USD 78 mn | 2.8% |
| 2 | China | USD 32 mn | 14.0% | USD 51 mn | 4.8% |
| 3 | India | USD 18 mn | 8.0% | USD 32 mn | 5.8% |
| 4 | Germany | USD 11 mn | 5.0% | USD 14 mn | 2.4% |
| 5 | Japan | USD 11 mn | 5.0% | USD 14 mn | 2.4% |
| 6 | Brazil | USD 11 mn | 5.0% | USD 17 mn | 3.9% |
| 7 | United Kingdom | USD 8.0 mn | 3.5% | USD 10.0 mn | 2.2% |
| 8 | France | USD 8.0 mn | 3.5% | USD 10.0 mn | 2.2% |
| 9 | Italy | USD 6.8 mn | 3.0% | USD 8.7 mn | 2.4% |
| 10 | Turkey | USD 6.8 mn | 3.0% | USD 10.0 mn | 3.8% |
| 11 | Spain | USD 4.1 mn | 1.8% | USD 5.2 mn | 2.4% |
| 12 | Canada | USD 3.8 mn | 1.6% | USD 4.8 mn | 2.4% |
| 13 | Mexico | USD 3.4 mn | 1.5% | USD 4.8 mn | 3.5% |
| 14 | South Korea | USD 3.1 mn | 1.4% | USD 4.3 mn | 3.5% |
| 15 | Russia | USD 3.1 mn | 1.4% | USD 3.9 mn | 2.4% |
| 16 | Indonesia | USD 2.7 mn | 1.2% | USD 4.3 mn | 4.6% |
| 17 | Australia | USD 2.7 mn | 1.2% | USD 3.4 mn | 2.3% |
| 18 | Egypt | USD 2.4 mn | 1.1% | USD 3.7 mn | 4.5% |
| 19 | Saudi Arabia | USD 2.4 mn | 1.1% | USD 3.7 mn | 4.5% |
| 20 | Pakistan | USD 2.4 mn | 1.1% | USD 4.1 mn | 5.6% |
| 21 | Iran | USD 2.0 mn | 0.9% | USD 2.6 mn | 2.4% |
| 22 | Poland | USD 2.0 mn | 0.9% | USD 2.9 mn | 3.5% |
| 23 | Argentina | USD 2.0 mn | 0.9% | USD 2.6 mn | 2.4% |
| 24 | Thailand | USD 2.0 mn | 0.9% | USD 2.9 mn | 3.5% |
| 25 | Netherlands | USD 2.0 mn | 0.9% | USD 2.6 mn | 2.4% |
| Rest of world | USD 14 mn | 6.3% | USD 20 mn | 3.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Medtronic
- B. Braun
- Teleflex
Group 2: Regional and specialist players
- SMI AG
- Assut Europe
- Peters Surgical
- Mani
- Resorba Medical
- Surgical Specialties
- CP Medical
- Samyang Biopharmaceuticals
- Dynek
- Riverpoint Medical
Group 3: Emerging and niche players
- Healthium Medtech
- Dolphin Sutures
- Lotus Surgicals
- Aurolab
- Futura Surgicare
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the absorbable PGA surgical sutures market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 3.5% is calculated from the resulting values.
The market is divided by construction, by surgery, by needle type, by suture size, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the absorbable PGA surgical sutures market?
The global absorbable PGA surgical sutures market is estimated at USD 220 mn in 2025 and USD 228 mn in 2026.
How fast will the absorbable PGA surgical sutures market grow?
It is forecast to reach USD 321 mn by 2036, a compound annual growth rate of 3.5% from 2026, an increase of USD 93 mn.
Which country is the largest market for absorbable PGA surgical sutures?
United States is the largest market by revenue at USD 59 mn in 2026, 26.0% of the global total. The three largest countries together hold 48.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 5.8% a year from 2026 to 2036.
Which absorbable PGA surgical sutures segment is largest?
In the by construction split, Braided and coated is the largest segment with 72.0% of 2026 revenue.
Who are the leading absorbable PGA surgical sutures companies?
Global leaders include Medtronic, B. Braun, Teleflex.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Diagnostic Exosome BiomarkersUSD 242 mn · 15.0% CAGR
- Continuous Peripheral Nerve Block CatheterUSD 243 mn · 5.0% CAGR
- Medical Device Cyber Risk QuantificationUSD 244 mn · 15.0% CAGR
- Dengue VaccinesUSD 247 mn · 22.0% CAGR
- Augmented Glenoid SystemsUSD 251 mn · 8.5% CAGR
- Automated CPR DeviceUSD 253 mn · 5.5% CAGR
- Multiplex Sepsis Biomarker PanelsUSD 203 mn · 12.0% CAGR
- Dental Oral MicrobiomeUSD 255 mn · 10.0% CAGR
← Abdominal Closure Systems Absorbable PGLA Surgical Sutures →